Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.38 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.38 |
| ▸ | PDE5A | O76074 | 1/20 | 0.38 |
| ▸ | CCR5 | P51681 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2495389 | 1.00 | FAAH (0.41) | FAAHTRPV1MGLLCYSLTR2CYSLTR1 | |
| SCHEMBL9559868 | 0.80 | CYSLTR2 (0.47) | FAAHTRPV1MGLLCYSLTR2CYSLTR1 | |
| SCHEMBL9834665 | 0.80 | CYSLTR2 (0.47) | FAAHTRPV1MGLLCYSLTR2CYSLTR1 | |
| SCHEMBL10651318 | 0.80 | CYSLTR2 (0.47) | FAAHTRPV1MGLLCYSLTR2CYSLTR1 | |
| SCHEMBL9559869 | 0.80 | CYSLTR2 (0.47) | FAAHTRPV1MGLLCYSLTR2CYSLTR1 | |
| SCHEMBL8496315 | 0.80 | CYSLTR2 (0.47) | FAAHTRPV1MGLLCYSLTR2CYSLTR1 | |
| SCHEMBL10383726 | 0.80 | CYSLTR2 (0.47) | FAAHTRPV1MGLLCYSLTR2CYSLTR1 | |
| SCHEMBL10383727 | 0.80 | CYSLTR2 (0.47) | FAAHTRPV1MGLLCYSLTR2CYSLTR1 | |
| SCHEMBL10651322 | 0.80 | CYSLTR2 (0.47) | FAAHTRPV1MGLLCYSLTR2CYSLTR1 | |
| SCHEMBL10520046 | 0.80 | CYSLTR2 (0.47) | FAAHTRPV1MGLLCYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9073938-B2 | Method for producing aromatic compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2015-07-07 | — | — | US | disclosed |
| EP-2147923-B1 | METHOD FOR PRODUCING AROMATIC COMPOUND | NIPPON KAYAKU KK (JP) | 2014-06-04 | — | — | EP | disclosed |
| EP-2371829-A1 | Method for producing benzo-trithiophene or benzo-triselenophene derivatives | Nippon Kayaku Kabushiki Kaisha (JP) | 2011-10-05 | — | — | EP | disclosed |
| US-20100137617-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-06-03 | — | — | US | disclosed |
| EP-2147923-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | Nippon Kayaku Kabushiki Kaisha (JP) | 2010-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137617-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SCLY, TYR, CBS | FAAH 3949/4885TRPV1 2508/4885MGLL 3844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.